JPRN-jRCTs031220614招募中4 期
on-antithrombotic therapy after transcatheter aortic valve implantation trial - NAPT trial
Hayashida Kentaro0 个研究点目标入组 360 人开始时间: 2023年2月7日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1) Patients who underwent transfemoral TAVI for aortic stenosis
- •2) Patients aged 20 years or older at the time of informed consent
- •3) Patients who have a thorough understanding of the subject of the study and who have agreed in writing to participate in the study
排除标准
- •1) Those with perioperative complications at the time of TAVI (conversion to open heart surgery, coronary artery occlusion, annulus rupture, cardiac tamponade, vascular dissection, cerebral infarction/cerebral hemorrhage, new atrial fibrillation, new atrioventricular block)
- •2) Individuals requiring antiplatelet agents for reasons other than TAVI (historty of myocardial infraction, history of PCI, history of EVT, hisotry of cerebral infraction and transient ischaemic stroke, with significant coronary artery narrowing, with high-grade carotid artery narrowing, and others judged as requiring antiplatelet therapy by the chief researcher or a sub-investigator)
- •3) Patients requiring oral anticoagulants (patients with atrial fibrillation, history of pulmonary embolism or deep venous thrombosis, and other patients who are deemed to require anticoagulation therapy by the investigator or subinvestigator)
- •4) Patients with eGFR <30 and patients on hemodialysis/peritoneal dialysis.
- •5) Patients with a history of valve replacement in the heart valves.
- •6) Patients who are pregnant, have childbearing potential, wish to become pregnant, or are breastfeeding.
- •7) Patients who have a concomitant medical illness associated with expected survival less than one year.
- •8) Patients who have the contraindications for aspirin.
- •9) Patients with a diagnosis of severe allergy to aspirin or a history of hypersensitivity.
- •10) Patients requiring a legally acceptable representative, patients unable to obtain written informed consent, or patients unable to understand the outline or purpose of the study.
- •11) Other patients for whom the principal investigator or the subinvestigator judges the participation in the study inappropriate.
研究者
相似试验
已完成
不适用
Anticoagulation following tissue aortic valve replacementAortic valve diseaseCirculatory SystemISRCTN51663857St George's Healthcare NHS Trust (UK)400
已完成
不适用
The retrospective study of antithrombotic therapies in cardiovascular diseases to elucidate the clinical problems and to develop management strategies.JPRN-UMIN000022469Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine / Tohoku Heart Failure Association33,700
已完成
不适用
Assessment of antithrombotic therapy before nerve or neuraxial block using thromboelastographyJPRN-UMIN000040140Asahikawa Medical University21
已完成
不适用
Thrombolytic Therapy In Sub Massive Pulmonary Thromo EmboliPulmonary Thrombo Emboli.Pulmonary embolism with mention of acute cor pulmonaleIRCT2014042017343N1cardiovascular research center,Shahid Beheshti University Of Medical Sience50
进行中（未招募）
1 期
ADALAATRIAL FIBRILLATION IN PATIENTS AFTER OCCLUSION OF THE LEFT ATRIAL APPENDAGE (LAAC)EUCTR2018-001013-32-ESHOSPITAL CLÍNIC BARCELONA160